Xenotransplantation and the Liver

Transplantation of the Liver

Volumn , Issue , 2005, Pages 1365-1377

  Platt, Jeffrey L ^a,b   Fox, Ira J ^c  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749344849     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0118-2.50089-6     Document Type: Chapter

References (117)

1. U.S. Department of Health and Human Services: 2001 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1991–2000. Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI. Accessed December 9, 2002 at: http://www.optn.org//data/annualReport.asp
2. U.S. Department of Health and Human Services: 1999 Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989–1998. (2000, February 21). Rockville, MD and Richmond, VA: HHS/HRSA/OSP/DOT and UNOS. Accesed November 10, 2001 at: http://www.unos.org/Data/anrpt_main.htm
3. A Kanazawa and JL Platt (2000) Prospects for xenotransplantation of the liver. Semin Liver Dis 20 511.
4. N Kanai and JL Platt (2000) Xenotransplantation of the liver. Clin Liver Dis 4 731.
5. TE Starzl, J Fung, A Tzakis, et al. (1993) Baboon-to-human liver transplantation. Lancet 341 65.
6. TE Starzl, LA Valdivia, N Murase, et al. (1994) The biological basis of and strategies for clinical xenotransplantation. Immunol Rev 141 213.
7. DH Van Thiel, HI Wright, S Fagiuoli and JS Gavaler (1996) Unusual indications for liver transplantation. RW Busuttil, GB Klintmalm (Eds) Transplantation of the Liver Philadelphia: Saunders 151.
8. IJ Fox, JR Chowdhury, SS Kaufman, et al. (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338 1422.
9. M Muraca, G Gerunda, G Neri, et al. (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359 317.
10. JR Gunsalus, DA Brady, SM Coulter, et al. (1997) Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat Med 3 48.
11. HM Blau and ML Springer (1995) Muscle-mediated gene therapy. N Engl J Med 333 1554.
12. JL Platt (1998) New directions for organ transplantation. Nature 392(Suppl), 11.
13. Y Dai, TD Vaught, J Boone, et al. (2002) Targeted disruption of the alphal,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20 251.
14. L Lai, D Kolber-Simonds, KW Park, et al. (2002) Production of α-1, 3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295 1089.
15. CJ Phelps, C Koike, TD Vaught, et al. (2003) Production of alpha 1, 3-galactosyltransferase-deficient pigs. Science 299 411.
16. K Reemtsma, BH McCracken, JU Schlegel, et al. (1964) Renal heterotransplantation in man. Ann Surg 160 384.
17. JS Allan (1996) Xenotransplantation at a crossroads: Prevention versus progress. Nat Med 2 18.
18. D White and J Wallwork (1993) Xenografting: Probability, possibility, or pipe dream? Lancet 342 879.
19. JL Piatt and JS Logan (1996) Use of transgenic animals in xenotransplantation. Transplant Rev 10 69.
20. DA Kelly and D Mayer (1999) Liver transplantation. DA Kelly (Eds) Diseases of the Liver and Biliary System in Children Oxford: Blackwell Science 293.
21. HR Rosen, CR Shackeleton and P Martin (1996) Indications for and timing of liver transplantation. P Martin, LS Friedman (Eds) The Medical Clinics of North America: Management of Chronic Liver Disease 80 Philadelphia: WB Saunders 1069.
22. TE Starzl, A Tzakis, JJ Fung, et al. (1994) Prospects of clinical xenotransplantation. Transplant Proc 26 1082.
23. S Taniguchi and DKC Cooper (1997) Clinical xenotransplantation—a brief review of the world experience. DKC Cooper, E Kemp, JL Platt, DJG White (Eds) Xenotransplantation 2nd ed. Berlin: Springer-Verlag 776.
24. TE Starzl, CW Putnam, KA Porter, et al. (1974) Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 6 129.
25. GR Giles, HJ Boehmig, H Amemiya, et al. (1970) Clinical heterotransplantation of the liver. Transplant Proc 2 506.
26. TE Starzl, TL Marchioro, TD Fans, et al. (1966) Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg 112 391.
27. TE Starzl (1969) Orthotopic heterotransplantation. Experience in Hepatic Transplantation Philadelphia: WB Saunders 408.
28. A Bertoye (1969) Essais de traitement de certaines infuggisances hepatiques graves par greffe hepatique heterlogue. Lyon Medical 222 345.
29. L Leger, Y Chapuis and JP Lenriot (1970) Heterotopic graft of baboon liver in a patient with fulminating hepatitis. Chirurgie 96 249.
30. P Marion (1969) Les transplantations cardiaques et les transplantations hepatiques. Lyon Medical 222 585.
31. P Marion, A Bertoye, P Mikaeloff, et al. (1970) Treatment of hepatic coma by auxiliary heterologous transplantation. Chirurgie 96 152.
32. M Pouyet and P Berard (1971) 2 cases of true heterotopic transplantation of the baboon liver in malignant acute hepatitis. Lyon Chirurgical 67 288.
33. J Motin (1974) JM Dubernard, M Bonneau, M Latour (Eds) Heterographs in primates Villeurbanne: Fondation Merieux 42. Quoted in
34. TE Starzl, N Murase, AG Tzakis, et al. (1994) Clinical xenotransplantation. Xenotransplantation 1 3.
35. L Makowka, GD Wu, A Hoffman, et al. (1994) Immunohistopathologic lesions associated with the rejection of a pig-to-human liver xenograft. Transplant Proc 26 1074.
36. TE Starzl (1997) Liver transplantation. Gastroenterology 112 288.
37. J Fung, A Rao, D Phil and TE Starzl (1997) Clinical trials and projected future of liver xenotransplantation. World J Surg 21 956.
38. K Paradis, G Langford, Z Long, et al. (1999) Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285 1236.
39. C Hammer (1998) Physiological obstacles after xenotransplantation. Ann N Y Acad Sci 862 19.
40. L Makowka, DV Cramer, A Hoffman, et al. (1995) The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59 1654.
41. RY Calne, HJO White, BM Herbertson, et al. (1968) Pig-to-baboon liver xenografts. Lancet 1 1176.
42. RY Calne, DR Davis, JR Pena, et al. (1970) Hepatic allografts and xenografts in primates. Lancet 1 103.
43. OM Martinez, SM Krams, M Sterneck, et al. (1992) Intragraft cytokine profile during human liver allograft rejection. Transplantation 53 449.
44. LK Kayler, RM Merion, S Lee, et al. (2002) Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 6 295.
45. M Rela, P Muiesan, H Vilca-Melendez, et al. (1999) Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 229 565.
46. JR Lake (1998) Hepatocyte transplantation. N Engl J Med 338 1463.
47. X Wang and R Andersson (1995) Hepatocyte transplantation: a potential treatment for acute liver failure. Scand J Gastroenterol 30 193.
48. N Kobayashi, T Fujiwara, KA Westerman, et al. (2000) Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287 1258.
49. N Kobayashi, M Ito, J Nakamura, et al. (2000) Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 31 851.
50. H Nagata, M Ito, J Cai, et al. (2003) Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 124 422.
51. CW Hoopes and JL Platt (1998) Hepatocyte transplantation: History, immunology, and potential for clinical application. Biotech Lab Int 3 11.
52. ASB Edge, ME Gosse and J Dinsmore (1998) Xenogeneic cell therapy: Current progress and future developments in porcine cell transplantation. Cell Transplant 7 525.
53. Y Wakizaka, T Miki, AS Rao, et al. (1997) Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation 4 262.
54. GM Abouna, JR Kirkley, CJ Hull, et al. (1969) Treatment of hepatic coma by extracorporeal pig-liver perfusion. Lancet 1 64.
55. RS Chari, BH Collins, JC Magee, et al. (1994) Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 331 234.
56. GM Abouna (1997) Extracorporeal xenogeneic liver perfusion for the treatment of hepatic failure. DKC Cooper, E Kemp, JL Platt, DJG White (Eds) Xenotransplantation: The Transplantation of Organs and Tissues Between Species 2nd ed. Berlin: Springer-Verlag
57. SP Horslen, JM Hammel, LW Fristoe, et al. (2000) Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 70 1472.
58. BH Collins, RS Chad, JC Magee, et al. (1994) Mechanisms of injury in porcine livers perfused with blood of humans with fulminant hepatic failure. Transplantation 58 1162.
59. PB Yu, W Parker, M Everett, et al. (1999) Immunochemical properties of anti-Gakα1–3Gal after sensitization with xenogeneic tissues. J Clin Immunol 19 116.
60. FD Watanabe, CJ Mullon, WR Hewitt, et al. (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 225 484.
61. H Bismuth, J Figueiro and D Samuel (1998) What should we expect from a bioartificial liver in fulminant hepatic failure? Artif Organs 22 26.
62. B Busse and JC Gerlach (1999) Bioreactors for hybrid liver support: historical aspects and novel designs. Ann N Y Acad Sci 875 326.
63. M Cascalho and JL Platt (2001) Xenotransplantation and other means of organ replacement. Nat Rev Immunol 1 154.
64. M Cascalho and JL Platt (2001) The immunological barrier to xenotransplantation. Immunity 14 437.
65. JL Platt (1995) Hyperacute xenograft rejection Austin, TX: Medical Intelligence Unit. RG Landes
66. JL Platt, RJ Fischel, AJ Matas, et al. (1991) Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52 214.
67. U Galili, MR Clark, SB Shohet, et al. (1987) Evolutionary relationship between the natural anti-Gal antibody and the Galα1–3Gal epitope in primates. Proc Nat Acad Sci U.S.A. 84 1369.
68. SJ Knechtle, PC Kolbeck, S Tsuchimoto, et al. (1987) Hepatic transplantation into sensitized recipients: Demonstration of hyperacute rejection. Transplantation 43 8.
69. RM Merion and LM Colletti (1990) Hyperacute rejection in porcine liver transplantation: I. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum. Transplantation 49 861.
70. M Shiraisha, T Oshiro, K Taira, et al. (2001) Improved hepatic microcirculation by human soluble urinary thrombomodulin in the xenoperfused porcine liver. Transplantation 71 1046.
71. SC Robson, DKC Cooper and AJF d'Apice (2000) Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7 166.
72. JH Lawson, L Daniels and JL Platt (1997) The evaluation of thrombomodulin activity in porcine to human xenotransplantation. Transplant Proc 29 884.
73. SS Lin, DL Kooyman, LJ Daniels, et al. (1997) The role of natural anti-Galα1–3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunol 5 212.
74. JR Leventhal, AP Dalmasso, JW Cromwell, et al. (1993) Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55 857.
75. SK Pruitt, AD Kirk, RR Bollinger, et al. (1994) The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57 363.
76. JC Magee, BH Collins, RC Harland, et al. (1995) Immunoglobulin prevents complement mediated hyperacute rejection inswine-to-primate xenotransplantation. J Clin Invest 96 2404.
77. JL Platt, GM Vercellotti, AP Dalmasso, et al. (1990) Transplantation of discordant xenografts: A review of progress. Immunol Today 11 450.
78. JS Logan and MJ Martin (1994) Transgenic swine as a recombinant production system for human hemoglobin. Methods Enzymol 231 435.
79. KR McCurry, DL Kooyman, CG Alvarado, et al. (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1 423.
80. GW Byrne, KR McCurry, MJ Martin, et al. (1997) Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63 149.
81. E Cozzi, N Yannoutsos, GA Langford, et al. (1997) Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. DKC Cooper, E Kemp, JL Platt, DJG White (Eds) Xenotransplantation: The Transplantation of Organs and Tissues Between Species 2nd ed. Berlin: Springer-Verlag 665.
82. AP Dalmasso, GM Vercellotti, JL Platt and FH Bach (1991) Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: Potential for prevention of xenograft hyperacute rejection. Transplantation 52 530.
83. MS Sandrin, WL Fodor, E Mouhtouris, et al. (1995) Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1 1261.
84. AD Thall, P Maly and JB Lowe (1995) Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 270 21437.
85. JL Platt (2002) Knocking out xenograft rejection. Nat Biotechnol 20 231.
86. JR Leventhal, AJ Matas, LH Sun, et al. (1993) The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 56 1.
87. KA Porter (1992) Renal transplantation. RH Heptinstall (Eds) 4th ed. Pathology of the Kidney 3 Boston: Little Brown 1799.
88. J Gugenheim, D Samuel, M Reynes and H Bismuth (1990) Liver transplantation across ABO blood group barriers. Lancet 336 519.
89. JL Platt, SS Lin and CGA McGregor (1998) Acute vascular rejection. Xenotransplantation 5 169.
90. SS Lin, BC Weidner, GW Byrne, et al. (1998) The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101 1745.
91. FH Bach, H Winkler, C Ferran, et al. (1996) Delayed xenograft rejection. Immunol Today 17 379.
92. JH Lawson and JL Platt (1996) Molecular barriers to xenotransplantation. Transplantation 62 303.
93. MW Chopek, RL Simmons and JL Platt (1987) ABO-incompatible renal transplantation: Initial immunopathologic evaluation. Transplant Proc 19 4553.
94. AD Bannett, RF McAlack, M Morris, et al. (1989) ABO incompatible renal transplantation: A qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 21 783.
95. JM Gloor, DJ Lager, SB Moore, et al. (2003) ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 75 971.
96. FH Bach, WW Hancock and C Ferran (1997) Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 18 483.
97. AP Dalmasso, T He and BA Benson (1996) Human IgM xenoreactive antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 3 54.
98. A Dorling, C Stocker, T Tsao, et al. (1996) In vitro accommodation of immortalized porcine endothelial cells: Resistance to complement-mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 62 1127.
99. SS Lin, MJ Hanaway, GV Gonzalez-Stawinski, et al. (2000) The role of anti-Galα1–3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (Rapid Communication) 70 1667.
100. W Parker, S Saadi, SS Lin, et al. (1996) Transplantation of discordant xenografts: A challenge revisited. Immunol Today 17 373.
101. GL Bumgardner, S Chen, R Hoffman, et al. (1989) Afferent and efferent pathways in T cell responses to MHC class I+, II− hepato-cytes. Transplantation 47 163.
102. GL Bumgardner and CG Orosz (2000) Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev 174 260.
103. DH Sachs and T Sablinski (1995) Tolerance across discordant xenogeneic barriers. Xenotransplantation 2 234.
104. ST Ildstad, MS Vacchio, PM Markus, et al. (1992) Cross-species transplantation tolerance: Rat bone marrow–derived cells can contribute to the ligand for negative selection of mouse T cell receptor Vb in chimeras tolerant to xenogeneic antigens (mouse + rat mouse). J Exp Med 175 147.
105. Y Zhao, K Swenson, JJ Sergio, et al. (1996) Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 2 1211.
106. L Inverardi, M Samaja, R Motterlini, et al. (1992) Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 149 1416.
107. TE Starzl, AJ Demetris, N Murase, et al. (1992) Cell migration, chimerism, and graft acceptance. Lancet 339 1579.
108. ZE Holzknecht, S Coombes, BA Blocher, et al. (2000) Evidence of immunocomplex formation in pulmonary xenografts. Transplant Proc 32 1141.
109. JH Lawson and JL Platt (2000) Xenotransplantation: Prospects for clinical application. W Owen, B Pereira, M Sayegh (Eds) Dialysis and Transplantation: A Companion to Brenner and Rector's The Kidney Philadelphia: WB Saunders 653.
110. CW Daggett, M Yeatman, AJ Lodge, et al. (1998) Total respiratory support from swine lungs in primate recipients. J Thor Cardiovasc Surg 115 19.
111. J Edwards (1981) Complement activation by xenogeneic red blood cells. Transplantation 31 226.
112. MF Donato, E Arosio, E Berti, et al. (1993) Immunopathology of liver allografts and xenografts in nonhuman primates. Transplant Proc 25 850.
113. M Desille, L Corcos, A L'Helgoualc'h, et al. (1999) Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 68 1437.
114. C Patience, Y Takeuchi and RA Weiss (1997) Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3 282.
115. SL Nyberg, JR Hibbs and JA Hardin (1999) Transfer of porcine endogenous retrovirus across hollow fiber membranes: Significance to a bioartificial liver. Transplantation 67 1251.
116. C Patience, GS Patton, Y Takeuchi, et al. (1998) No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352 699.
117. JL Platt (2000) Xenoassistance devices for the treatment of hepatic failure: Challenges and controversies. Transplant Proc 32 2693.